| Market Cap | ₹1,908Cr |
| ROE | 16.57% |
| P/E Ratio(TTM) | 33.66 |
| EPS(TTM) | 19.61 |
| P/B Ratio | 5.58 |
| Dividend Yield | 0.70% |
| Industry P/E | 39.79 |
| Book Value | 118.32 |
| Debt to Equity | 0.01 |
| Face Value | 1 |
| Parent Organisation | Amrutanjan Health Care Limited |
| Managing Director | S. Sambhu Prasad |
| Founded | 1893 |
| NSE Symbol | AMRUTANJAN |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 59.51 | ||
| Ajanta Pharma | NA (0.00%) | 33.61 | ||
| Gland Pharma | NA (0.00%) | 35.69 | ||
| Eris Lifesciences | NA (0.00%) | 51.62 |